Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention

<div>Correlations of sLOX-1 concentrations with LDL-c concentrations (a) and HDL-c concentrations (b). sLOX-1 = soluble lectin-like oxidized low-density lipoprotein receptor-1, LDL-c = low-density lipoprotein cholesterol, HDL-c = high-density lipoprotein cholesterol.</div>

Disease Markers

fig4

Figure 4

Figure 4: Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention 

Figure 4 | Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention 